Compare · HCA vs PACS
HCA vs PACS
Side-by-side comparison of HCA Healthcare Inc. (HCA) and PACS Group Inc. (PACS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HCA and PACS operate in Hospital/Nursing Management (Health Care), so they compete in similar markets.
- HCA is the larger of the two at $92.83B, about 13.3x PACS ($6.96B).
- PACS has been more active in the news (7 items in the past 4 weeks vs 2 for HCA).
- HCA has more recent analyst coverage (25 ratings vs 6 for PACS).
- Company
- HCA Healthcare Inc.
- PACS Group Inc.
- Price
- -
- -
- Market cap
- $92.83B
- $6.96B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Hospital/Nursing Management
- Hospital/Nursing Management
- Exchange
- NYSE
- NYSE
- IPO
- 2011
- 2024
- News (4w)
- 2
- 7
- Recent ratings
- 25
- 6
HCA Healthcare Inc.
HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2020, it operated 185 hospitals, which included 178 general, acute care hospitals, as well as five psychiatric hospitals and two rehabilitation hospitals; 121 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Latest HCA
- HCA Healthcare, Inc. to Present at September Conferences
- HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
- HCA Healthcare Inc. filed SEC Form 8-K: Other Events, Creation of a Direct Financial Obligation
- SEC Form 10-Q filed by HCA Healthcare Inc.
- HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- HCA Healthcare Reports Second Quarter 2026 Results
- HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call
- HCA Healthcare Previews Second Quarter 2026 Results
- HCA downgraded by Barclays with a new price target
Latest PACS
- Co-Founder, CEO & Chairman Murray Jason Hulse sold $6,611,433 worth of shares (150,550 units at $43.92) as part of a pre-agreed trading plan, decreasing direct ownership by 0.27% to 54,694,866 units (SEC Form 4)
- Co-Founder, CEO & Chairman Murray Jason Hulse sold $10,437,434 worth of shares (236,116 units at $44.20) as part of a pre-agreed trading plan, decreasing direct ownership by 0.43% to 54,845,416 units (SEC Form 4)
- President & COO Jergensen Joshua sold $1,823,689 worth of shares (40,000 units at $45.59) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 2,536,320 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by PACS Group Inc.
- PACS Group, Inc. Reports Second Quarter 2026 Results
- PACS Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by PACS Group Inc.
- PACS Group Schedules Second Quarter 2026 Earnings Release and Conference Call
- President & COO Jergensen Joshua sold $1,800,718 worth of shares (40,000 units at $45.02) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 2,576,320 units (SEC Form 4)
- Director Hancock Mark sold $613,795 worth of shares (13,628 units at $45.04) as part of a pre-agreed trading plan, decreasing direct ownership by 0.03% to 53,906,884 units (SEC Form 4)